1.32
Talphera Inc stock is traded at $1.32, with a volume of 688.89K.
It is up +5.60% in the last 24 hours and up +23.36% over the past month.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
See More
Previous Close:
$1.25
Open:
$1.28
24h Volume:
688.89K
Relative Volume:
0.28
Market Cap:
$58.26M
Revenue:
$2.82M
Net Income/Loss:
$-14.20M
P/E Ratio:
-1.5529
EPS:
-0.85
Net Cash Flow:
$-15.13M
1W Performance:
+3.94%
1M Performance:
+23.36%
6M Performance:
+161.90%
1Y Performance:
+91.28%
Talphera Inc Stock (TLPH) Company Profile
Compare TLPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
TLPH
Talphera Inc
|
1.32 | 58.26M | 2.82M | -14.20M | -15.13M | -0.85 |
|
ZTS
Zoetis Inc
|
118.80 | 53.24B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.14 | 45.14B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.68 | 42.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
VTRS
Viatris Inc
|
10.66 | 12.35B | 14.33B | -3.79B | 1.84B | -3.17 |
|
UTHR
United Therapeutics Corp
|
471.92 | 20.08B | 3.08B | 1.24B | 1.07B | 25.61 |
Talphera Inc Stock (TLPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-28-25 | Initiated | Rodman & Renshaw | Buy |
| Jul-20-20 | Downgrade | Credit Suisse | Neutral → Underperform |
| Nov-11-19 | Downgrade | Credit Suisse | Outperform → Neutral |
| Aug-05-19 | Resumed | Credit Suisse | Outperform |
| Jul-10-19 | Resumed | Credit Suisse | Outperform |
| Apr-24-19 | Resumed | B. Riley FBR | Buy |
| Feb-15-19 | Initiated | Credit Suisse | Outperform |
| Oct-23-18 | Initiated | B. Riley FBR | Buy |
| Oct-13-17 | Downgrade | Jefferies | Buy → Hold |
| Oct-13-17 | Reiterated | RBC Capital Mkts | Outperform |
| Jul-14-17 | Resumed | Jefferies | Buy |
| Sep-15-16 | Reiterated | ROTH Capital | Buy |
| Aug-05-16 | Downgrade | Stifel | Buy → Hold |
| Oct-30-15 | Upgrade | Jefferies | Hold → Buy |
| Oct-05-15 | Reiterated | ROTH Capital | Buy |
| Sep-02-15 | Initiated | H.C. Wainwright | Buy |
| Jul-10-15 | Resumed | ROTH Capital | Buy |
| May-06-15 | Reiterated | Mizuho | Neutral |
| May-05-15 | Reiterated | RBC Capital Mkts | Outperform |
| Mar-10-15 | Reiterated | RBC Capital Mkts | Outperform |
| Mar-09-15 | Downgrade | Mizuho | Buy → Neutral |
View All
Talphera Inc Stock (TLPH) Latest News
Can Talphera Inc. (R5XA) stock reach $200 price targetJuly 2025 Volume & Trade Opportunity Analysis - newser.com
Talphera Inc. stock chart pattern explained2025 Volatility Report & AI Powered Buy/Sell Recommendations - newser.com
Can Talphera Inc. stock withstand economic slowdownJuly 2025 Highlights & Expert Approved Momentum Ideas - newser.com
Published on: 2025-11-16 14:59:56 - newser.com
What technical patterns form on Talphera Inc. (R5XA) stock chartsJuly 2025 PreEarnings & Community Shared Stock Ideas - newser.com
Is Talphera Inc. showing signs of accumulation2025 Earnings Impact & Consistent Return Investment Signals - newser.com
Is Talphera Inc. stock supported by strong cash flowsQuarterly Market Review & AI Enhanced Execution Alerts - newser.com
Key resistance and support levels for Talphera Inc.2025 Support & Resistance & Fast Gain Swing Alerts - newser.com
Using data tools to time your Talphera Inc. exitTrade Risk Summary & Risk Controlled Stock Pick Alerts - newser.com
Talphera Inc. Stock Analysis and ForecastSwing Trading Ideas & Rapid Capital Gain - earlytimes.in
How Talphera Inc. stock compares to market leaders2025 Market Trends & Daily Oversold Bounce Ideas - newser.com
A better buy-in window may exist right now for Talphera Inc (TLPH) - setenews.com
How strong dollar benefits Talphera Inc. (R5XA) stockWeekly Investment Report & Reliable Entry Point Alerts - newser.com
Talphera, Inc. Earnings Call: Balancing Achievements and Challenges - TipRanks
Talphera signals study completion in first half of 2026 as new site activations delay NEPHRO timeline - MSN
Talphera (TLPH) Q3 2025 Earnings Call Transcript - AOL.com
Is Talphera Inc. stock trading near support levelsJuly 2025 Recap & AI Powered Buy and Sell Recommendations - newser.com
Talphera Inc (TLPH) Q3 2025 Earnings Call Highlights: Strategic Investments and Regulatory ... By GuruFocus - Investing.com Canada
Talphera: Q3 Earnings Snapshot - Stamford Advocate
Talphera Reports Q3 2025 Financial Results and Updates - TipRanks
Talphera Inc (TLPH) Q3 2025 Earnings Call Highlights: Strategic Investments and Regulatory ... - Yahoo Finance
Earnings call transcript: Talphera Q3 2025 focuses on Nifamostat progress By Investing.com - Investing.com Nigeria
Earnings call transcript: Talphera Q3 2025 focuses on Nifamostat progress - Investing.com
Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update - PR Newswire
What drives Talphera Inc stock priceStock Buyback Updates & Free Stock Predictions and Analysis - earlytimes.in
Earnings Outlook For Talphera - Benzinga
Talphera Inc Stock (TLPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):